Innovate therapeutic targets for autoimmune diseases: insights from proteome-wide mendelian randomization and Bayesian colocalization

Innovate therapeutic targets for autoimmune diseases: insights from proteome-wide mendelian randomization and Bayesian colocalization

Background Despite growing knowledge regarding the pathogenesis of autoimmune diseases (ADs) onset, the current treatment remains unsatisfactory. This study aimed to identify innovative therapeutic targets for ADs through various analytical approaches.Research design and methods Utilizing Mendelian...

Full description

Bibliographic Details
Main Authors:	Qiubai Jin, Feihong Ren, Ping Song
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Autoimmunity
Subjects:	Autoimmune diseases plasma proteome therapeutic target Mendelian randomization Bayesian co-localization analysis
Online Access:	https://www.tandfonline.com/doi/10.1080/08916934.2024.2330392

Similar Items

Proteome-Wide Mendelian Randomization and Colocalization Analysis Identify Therapeutic Targets for Knee and Hip Osteoarthritis
by: Mingrui Zou, et al.
Published: (2024-03-01)

Potential therapeutic targets for membranous nephropathy: proteome-wide Mendelian randomization and colocalization analysis
by: Zhihang Su, et al.
Published: (2024-04-01)

Exploring potential therapeutic targets for asthma: a proteome-wide Mendelian randomization analysis
by: Yuhan Jiang, et al.
Published: (2024-10-01)

Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analysesResearch in context
by: Jie Chen, et al.
Published: (2023-03-01)

Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma
by: Long Zhang, et al.
Published: (2024-04-01)

Therapeutic targets for muscle weakness in older adults: proteome-wide Mendelian randomization and colocalization analyses
by: Shuai-Kang Wang, et al.
Published: (2024-09-01)

Proteomic analysis reveals potential therapeutic targets for childhood asthma through Mendelian randomization
by: Yi‐Qing Wu, et al.
Published: (2024-05-01)

Therapeutic targets for age-related macular degeneration: proteome-wide Mendelian randomization and colocalization analyses
by: Kun-Lin Pu, et al.
Published: (2024-06-01)

Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses
by: Min Cao, et al.
Published: (2024-04-01)

Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers
by: Feihong Ren, et al.
Published: (2023-09-01)

Proteome‐Wide Mendelian Randomization Identifies Therapeutic Targets for Abdominal Aortic Aneurysm
by: Ka Zhang, et al.
Published: (2025-02-01)

Proteome-wide Mendelian randomization identified potential drug targets for migraine
by: Zhonghua Xiong, et al.
Published: (2024-09-01)

Novel Protein Biomarkers and Therapeutic Targets for Type 1 Diabetes and Its Complications: Insights from Summary-Data-Based Mendelian Randomization and Colocalization Analysis
by: Mingrui Zou, et al.
Published: (2024-06-01)

Mendelian Randomization and Colocalization Analysis Reveal New Drug Targets for Oral Ulcer: A Mendelian Randomization Analysis
by: Xiaoyu Zhang, et al.
Published: (2025-02-01)

Proteome-wide mendelian randomization identifies novel therapeutic targets for chronic kidney disease
by: Pin Zhao, et al.
Published: (2024-09-01)

Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer
by: Siyu Zhou, et al.
Published: (2024-06-01)

Mendelian randomization and Bayesian model averaging of autoimmune diseases and Long COVID
by: Jieni Feng, et al.
Published: (2024-06-01)

Identifying new biomarkers and potential therapeutic targets for breast cancer through the integration of human plasma proteomics: a Mendelian randomization study and colocalization analysis
by: Jingshuang Song, et al.
Published: (2024-09-01)

Therapeutic targets for lung cancer: genome-wide Mendelian randomization and colocalization analyses
by: Yi Luan, et al.
Published: (2024-10-01)

Integrating plasma proteomes with genome-wide association data for causal protein identification in multiple myeloma
by: Qiangsheng Wang, et al.
Published: (2023-09-01)

Identification of potential drug targets for amyotrophic lateral sclerosis by Mendelian randomization analysis based on brain and plasma proteomics
by: Ni Yang, et al.
Published: (2024-10-01)

Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases
by: Junhang Li, et al.
Published: (2024-05-01)

Identification of novel drug targets for osteoarthritis by integrating genetics and proteomes from blood
by: Shan Song, et al.
Published: (2024-09-01)

PTGES2 and RNASET2 identified as novel potential biomarkers and therapeutic targets for basal cell carcinoma: insights from proteome-wide mendelian randomization, colocalization, and MR-PheWAS analyses
by: Qiu-Ju Han, et al.
Published: (2024-07-01)

Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis
by: Wenlong Zhao, et al.
Published: (2024-03-01)

Integrated analysis of Mendelian Randomization and Bayesian colocalization reveals bidirectional causal association between inflammatory bowel disease and psoriasis
by: Yangke Cai, et al.
Published: (2023-12-01)

Proteome‐Wide Mendelian Randomization Analysis Identified Potential Drug Targets for Atrial Fibrillation
by: Xinpei Wang, et al.
Published: (2023-08-01)

Identification of potential drug targets for insomnia by Mendelian randomization analysis based on plasma proteomics
by: Ni Yang, et al.
Published: (2024-04-01)

Proteome-wide Mendelian randomization and therapeutic targets for bladder cancer
by: Meng-Hua Wu, et al.
Published: (2024-12-01)

Multiple myeloma, IL6, and risk of schizophrenia: A Mendelian randomization, transcriptome, and Bayesian colocalization study
by: Shuyang Lin, et al.
Published: (2024-06-01)

Causal effects of plasma metabolites on autoimmune hepatitis (AIH): a bidirectional two-sample mendelian randomization study
by: Zhen Zheng, et al.
Published: (2024-10-01)

Unveiling Novel Protein Biomarkers for Psoriasis Through Integrated Analysis of Human Plasma Proteomics and Mendelian Randomization
by: Mao R, et al.
Published: (2024-12-01)

Proteome-Wide Mendelian Randomisation Identifies Causal Links of Plasma Proteins With Periodontitis
by: Chaoning Zhan, et al.
Published: (2024-12-01)

Unveiling new protein biomarkers and therapeutic targets for acne through integrated analysis of human plasma proteomics and genomics
by: Sui Deng, et al.
Published: (2024-10-01)

Evaluation of circulating plasma proteins in prostate cancer using mendelian randomization
by: Long Cheng, et al.
Published: (2024-09-01)

Proteome-wide Mendelian randomization identifies causal plasma proteins in prostate cancer development
by: Jian Wu, et al.
Published: (2025-02-01)

Novel therapeutic targets for primary open-angle glaucoma identified through multicenter proteome-wide mendelian randomization
by: Weichen Yuan, et al.
Published: (2024-08-01)

Plasma proteins and psoriatic arthritis: a proteome-wide Mendelian randomization study
by: Heran Zhao, et al.
Published: (2024-07-01)

Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome
by: Shucheng Si, et al.
Published: (2024-06-01)

Identifying novel potential drug targets for endometriosis via plasma proteome screening
by: Tian Tao, et al.
Published: (2024-07-01)